Publications

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

August 22nd, 2023

View details

Deep learning integrates histopathology and proteogenomics at a pan-cancer level

August 14th, 2023

View details

Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer

July 24th, 2023

View details

Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

July 14th, 2023

View details

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer

July 10th, 2023

View details

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors

July 10th, 2023

View details

Proteogenomic data and resources for pan-cancer analysis

June 9th, 2023

View details

LENS: Landscape of Effective Neoantigens Software

May 15th, 2023

View details

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

May 1st, 2023

View details

PepSim: T-cell cross-reactivity prediction via comparison of peptide sequence and peptide-HLA structure

April 28th, 2023

View details

Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer

April 17th, 2023

View details

Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development

March 31st, 2023

View details

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

March 22nd, 2023

View details

An interpretable ML model to characterize patient-specific HLA-I antigen presentation

March 13th, 2023

View details

Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors

March 9th, 2023

View details

Contact Info

Publications by BreakBio team members and advisors

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer

Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors

Proteogenomic data and resources for pan-cancer analysis

LENS: Landscape of Effective Neoantigens Software

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

PepSim: T-cell cross-reactivity prediction via comparison of peptide sequence and peptide-HLA structure

Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer

Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor development

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

An interpretable ML model to characterize patient-specific HLA-I antigen presentation

Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors

Contact

Link

Contact Info

Publications by BreakBio team members and advisors

Discover Our Innovative Cancer Solutions.

Contact

Discover Our Innovative
Cancer Solutions.